Piper Jaffray Starts Aptevo Therapeutics (APVO) at Overweight

September 9, 2016 9:40 AM EDT
Get Alerts APVO Hot Sheet
Price: $2.36 +2.16%

Rating Summary:
    1 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 18 | New: 30
Trade APVO Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Piper Jaffray earlier initiated coverage on Aptevo Therapeutics (NASDAQ: APVO) with an Overweight rating and a price target of $7.00.

For an analyst ratings summary and ratings history on Aptevo Therapeutics click here. For more ratings news on Aptevo Therapeutics click here.

Shares of Aptevo Therapeutics closed at $2.20 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Hot New Coverage, New Coverage

Related Entities

Piper Jaffray

Add Your Comment